Abstract: An additive manufacturing apparatus includes a first print module includes a first stage configured to hold a first component and a first radiant energy device. The resin support is configured to be positioned between the first stage and the first radiant energy device. A second print module includes a second stage configured to hold a second component and a second radiant energy device. The resin support is configured to be positioned between the second stage and the second radiant energy device. A control system is configured to translate the resin support based on a condition of the first print module and the second print module through the first print module and the second print module.

Abstract: A system and platform are provided that enables end-users to gain insight into group and individual practices. Those insights may be obtained for any desirable aspect of each practice and the collection of practices including, but not limited to, financial information, medical information, human resources information, and patient information. That information can be used by group management to identify best practices, and it can be used to advise individual practices on strengths to be reinforced and weaknesses to be addressed. That information may be conveyed to group management and individual practices in the form of dashboards customizable to the particular functions of specific users and their personas.

Abstract: An additive manufacturing apparatus is provided herein that includes a resin support configured to support a resin. A support plate includes a window. A stage is configured to hold one or more cured layers of the resin to form a component. Each cured layer is formed with the stage in a respective cure position. A radiant energy device is positioned on an opposite side of the resin support from the stage and is operable to generate and project radiant energy in a patterned image through the window. An actuator is operably coupled with the stage and is configured to move the stage in a Z-axis direction to place the stage in a removal position. The component contacts one of the resin support or the resin supported by the resin support in the removal position.

Abstract: A system and platform are provided that enables end-users to gain insight into group and individual practices. Those insights may be obtained for any desirable aspect of each practice and the collection of practices including, but not limited to, financial information, medical information, human resources information, and patient information. That information can be used by group management to identify best practices, and it can be used to advise individual practices on strengths to be reinforced and weaknesses to be addressed. That information may be conveyed to group management and individual practices in the form of dashboards customizable to the particular functions of specific users and their personas.

Abstract: An additive manufacturing apparatus includes a support plate including a window. A stage is configured to hold one or more cured layers of the resin to form a component. A radiant energy device positioned on an opposite side of the support plate from the stage and operable to generate and project radiant energy in a patterned image through the window. An actuator is operably coupled with the stage and is configured to move the stage between a curing position and a removal position. The curing position can be offset from the removal position.

Abstract: A method of manufacturing ceramic tape includes a step of directing a tape of partially-sintered ceramic into a furnace. The tape is partially-sintered such that grains of the ceramic are fused to one another yet the tape still includes at least 10% porosity by volume, where the porosity refers to volume of the tape unoccupied by the ceramic. The method further includes steps of conveying the tape through the furnace and further sintering the tape as the tape is conveyed through the furnace. The porosity of the tape decreases during the further sintering step.

Abstract: An additive manufacturing apparatus includes a feed module and a take-up module that are configured to operably couple with a foil. A stage is configured to hold one or more cured layers of a resin that form a component. A radiant energy device is positioned opposite to the at least one stage. The radiant energy device is operable to generate and project radiant energy in a predetermined pattern. An actuator is configured to change a relative position of the at least one stage and the foil. An accumulator is positioned between the feed module and the take-up module. The accumulator is configured to retain an intermediate portion of the foil to allow a first portion of the foil upstream of the accumulator to move at a first speed and a second portion of the foil downstream of the accumulator to move at a second speed during a defined time period.

Abstract: A cell culture vessel has a wall and cell culture surface having a plurality of microcavities for culturing cells in three-dimensional conformation, referred to as “spheroids”. The inner surface of the wall and the cell culture surface define a cell culture chamber of the vessel. The wall is attached to the cell culture surface in a way that does not provide flat surfaces on or around the cell culture surface so that the vessel provides an environment suitable for the production of a homogeneous population of three-dimensional cell clusters, or spheroids.

Abstract: A lubricant pump system includes a pump assembly which has a housing with an interior pumping chamber having an inlet. At least one pumping unit is disposed at least partially within the pumping chamber and is configured to displace lubricant from the pumping chamber through an outlet. The housing has a pump interface with an opening fluidly coupleable with the pumping chamber inlet and a pump valve controlling lubricant flow through the pump interface opening. A reservoir includes a body connectable with the pump housing and having a central axis, an interior storage chamber for containing a quantity of lubricant and a reservoir interface engageable with the pump interface. The reservoir interface includes an opening fluidly coupleable with the storage chamber and fluidly coupleable with the pump interface opening. The reservoir body includes a reservoir valve controlling lubricant flow through the reservoir interface opening.

Abstract: Cell culture devices comprise a frame comprising an open well disposed therein and a fluid inlet area in communication with the open well. The open well comprises a top opening, a bottom plate comprising a microcavity substrate, the bottom plate defining a major surface, and one or more sidewalls extending from the bottom plate to the top opening. The microcavity substrate comprises a plurality of microcavities, and each microcavity is configured such that cells cultured in the well form a spheroid. The cell culture device may be a reservoir open well microcavity plate used for spheroid cell culture.

Abstract: Methods, systems and devices for determining contrast sensitivity function in a subject without requiring perceptual report by the subject.

Abstract: In an aspect, an assembly for gauging fuel of an electric aircraft is presented. A assembly includes a plurality of battery packs of an electric aircraft. Each battery pack of a plurality of battery packs includes a plurality of battery modules. An assembly include at least a battery sensor in electronic communication with a battery pack of a plurality of battery packs. At least a battery sensor is configured to measure battery data. An assembly includes a computing device communicatively connected to at least a battery sensor. A computing device is configured to receive battery data from at least a battery sensor. A computing device is configured to determine a landing energy as a function of battery data. A computing device is configured to provide landing energy to a user through a display.

Abstract: The present disclosure provides alternative nucleosides, nucleotides, and nucleic acids, and methods of using them. In some aspects, the disclosure provides mRNA wherein the uracil content has been modified and which may be particularly effective for use in therapeutic compositions, because they may benefit from both high expression levels and limited induction of the innate immune response. In some aspects, the disclosure provides methods for the production of pharmaceutical compositions including mRNA without reverse phase chromatography.

Abstract: An apparatus for venting battery ejecta for use in an electric aircraft is presented. The apparatus includes a battery module with a plurality of electrochemical cells. The electrochemical cells of the plurality of electrochemical cells are separated by a carbon fiber barrier. Venting port of a plurality of venting ports is configured to vent an electrochemical cell of the plurality of electrochemical cells using a venting path of a plurality of venting paths, wherein the plurality of vent ports is fluidly connected to the plurality of venting paths and the plurality of venting paths are fluidly connected to at least an outlet. Venting paths direct the battery ejecta from the electrochemical cell to the outside of the electric aircraft through at least an outlet.

Abstract: An apparatus for venting battery ejecta for use in an electric aircraft is presented. The apparatus includes a battery module with a plurality of electrochemical cells. The electrochemical cells of the plurality of electrochemical cells are separated by a carbon fiber barrier. Venting port of a plurality of venting ports is configured to vent an electrochemical cell of the plurality of electrochemical cells using a venting path of a plurality of venting paths, wherein the plurality of vent ports is fluidly connected to the plurality of venting paths and the plurality of venting paths are fluidly connected to at least an outlet. Venting paths direct the battery ejecta from the electrochemical cell to the outside of the electric aircraft through at least an outlet.

Abstract: Disclosed herein are methods for purifying RNA comprising poly A. Also disclosed herein are compositions such as surfaces and oligonucleotides for purifying RNA comprising polyA. Other embodiments are also disclosed. Commercially-available resins having polythymidine oligonucleotide ligands typically contain less than 30 thymidine (2?deoxy) residues and some commercial resin suppliers utilize a distribution of dT chain lengths, not of a discreet length.

Abstract: Aspects of the present disclosure are generally related to a battery pack having a carbon fiber battery case, the battery pack comprising a plurality of pouch cells. Further, the battery pack having a carbon fiber battery case may include a casing formed with carbon fiber, the casing having one or more carbon fiber separation sheets and, the casing configured to dissipate heat from the plurality of pouch cells in a direction along carbon fibers of the casing.

Abstract: A flame retardant lamp includes a lamp body, a printed circuit board (PCB), a power supply, a light-emitting plate, a controller, a driving circuit, and a first temperature sensor. The PCB, the power supply, and the light-emitting plate are disposed inside the lamp body, the controller and the driving circuit are disposed on the PCB, and the first temperature sensor is disposed on the light-emitting plate. The controller is electrically connected to the light-emitting plate through the driving circuit, the first temperature sensor is electrically connected to an input end of the controller, and the power supply is electrically connected to a power supply end of the PCB.

Abstract: Herein disclosed is a mucoadhesive including a bacterial cellulose, and a bioadhesive incorporated to the bacterial cellulose, wherein the bioadhesive comprises a polymer or a dendrimer, wherein the polymer and the dend rimer are grafted with a moiety which forms covalent interactions with a tissue surface in the presence of a stimulus. A method of forming the mucoadhesive is also disclosed. The method includes providing a bacterial cellulose, providing a bioadhesive comprising a polymer or a dendrimer, wherein the polymer and the dendrimer are grafted with a moiety which forms covalent interactions with a tissue surface in the presence of a stimulus, and incorporating the bioadhesive to the bacterial cellulose. In the preferred embodiment, the dendrimer grafted with the moiety is Poly(amidoamine) (PAMAM) dendrimer grafted with 4-[3-(trifluoromethyl)-3H-diazirin-3-yl] benzyl bromide (PAMAM-g-diazirine) and the stimulus is UV light.

Abstract: Provided is a method including receiving, by a user device, a request from an identity service to approve communicating a user proof-of-identity to a relying party. A user of the user device is prompted to request a one-time transaction identifier based on the request. Based on a first input from the user, the user device requests the one one-time transaction identifier from the identity service. In response to the request for the one-time transaction identifier, the user device receives the one-time transaction identifier from the identity server and displays the one-time transaction identifier on a first user device screen. The user inputs the one-time transaction identifier on a second user device screen and the user device communicates the one-time transaction identifier to the identity service. In response to receiving the at least one inputted one-time transaction identifier, the relying party determines whether to approve or deny a transaction.